Loading...
Please wait, while we are loading the content...
Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PET.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Hirakata, Tomoko Yanagita, Yasuhiro Fujisawa, Tomomi Fujii, Takaaki Kinoshita, Teruhiko Horikoshi, Hiroyuki Oya, Nariyuki Akiyoshi, Tsukasa Iijima, Misa Miyamoto, Takeshi Kuwano, Hiroyuki |
| Copyright Year | 2014 |
| Abstract | BACKGROUND The aim of this prospective study of patients with breast cancer was to identify non-responders to docetaxel in neoadjuvant chemotherapy (NCT) using fluorine-18-fluorodeoxyglucose positron-emission tomography ((18)F-FDG-PET). PATIENTS AND METHODS We analyzed the maximum standardized uptake value (SUVmax) of (18)F-FDG-PET before and after the first course and the reduction rate in tumor size shown by magnetic resonance imaging (MRI) before the first and after the fourth course of docetaxel. RESULTS None of the eight patients (0%) whose SUVmax decrease was less than 18% revealed a clinical partial response or clinical complete response; Seven out of the sixteen patients (44%) with an SUVmax decrease over 45% achieved a complete response. CONCLUSION An SUVmax reduction rate less than 18% is observed in patients with breast cancer after the first course of docetaxel in NCT and may be indicator of non-response to docetaxel. |
| File Format | PDF HTM / HTML |
| PubMed reference number | 24403466 |
| Journal | Medline |
| Volume Number | 34 |
| Issue Number | 1 |
| Journal | Anticancer research |
| Alternate Webpage(s) | https://gair.media.gunma-u.ac.jp/dspace/bitstream/10087/8600/4/AR%20published.pdf |
| Alternate Webpage(s) | https://gair.media.gunma-u.ac.jp/dspace/bitstream/10087/8600/1/%E5%86%85%E5%AE%B9%E8%A6%81%E6%97%A81467.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
